Neutralizing Epitopes on the Respiratory Syncytial Virus Fusion Glycoprotein
The respiratory syncytial virus viral fusion glycoprotein (RSV F) is the major target of neutralizing antibodies, making it a target for vaccine development. This article, published in Current Opinion in Virology, summarizes recently determined structures of RSV F in prefusion and postfusion conformations and discusses how this influences vaccine development. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: McLellan JS
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: McLellan JS. Neutralizing Epitopes on the Respiratory Syncytial Virus Fusion Glycoprotein. Current Opinion in Virology. 2015;11:70-75.
Resource types: Peer-reviewed journal
Diseases/vaccines: Respiratory syncytial virus (RSV)